Alzheimer's Disease International (ADI)
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
A commentary in response to the recent Cochrane review of clinical trial data on different anti-amyloid treatments, that states these medicines show ‘no clinically meaningful benefit’ for people with Alzheimer’s.
On 15 April, at the ADI Conference in Lyon, France, ADI shared the Alzheimer’s Disease Atlas, a first-of-its-kind website mapping the global landscape of Alzheimer’s disease.
DY Suharya, Director of ADI Asia Pacific, and Shyh Poh Teo, Director of Demensia Brunei, reflect on the 2023 Asia Pacific Regional Conference as co-organisers of the event.
October signaled another busy month for ADI, with our and board members travelling internationally to capitalize on the growing momentum; from Buenos Aires, Brunei Darussalam, Helsinki, Lausanne, Tbilisi, to The Hague.
As World Alzheimer’s Month comes to a close, we reflect on some of the highlights from this year’s campaign
ADI member Dementia Australia has developed an app to help support brain health and encourage more timely dementia diagnoses.
As ADI prepares to attend the G7 summit in Hiroshima, Japan, DY Suharya writes about the journey of making dementia a priority at the G7 summit.
Silverado Senior Living is the first care home provider to receive ADI Accreditation since the launch of the accreditation programme in 2021.
Earlier this year, Alzheimer’s Disease Association of the Philippines partnered with Memory Lane Games to build a culturally relevant and customised cognitive game app for carers and people living with dementia in the Philippines.
In this blog, members of the ADI team look back at 2022 and write about their hopes and aspirations for 2023.